What are KOD's recent SEC filings?
Kodiak Sciences Inc. filed an 8-K on November 12, 2026, reporting its financial results for the quarter ended September 30, 2026, along with business highlights via an attached press release.
View full filing details →Kodiak Sciences Inc. filed its quarterly report on Form 10-Q for the period ending September 30, 2026, reporting financial results and business updates. The filing includes details on research and development expenses across its KSI-101, KSI-501, and ABC platform programs, as well as equity incentive plan activity.
View full filing details →Baker Brothers Life Sciences, L.P. and affiliated holder 667, L.P. filed an amended Schedule 13D reporting combined beneficial ownership of 21,860,941 shares, or 34.8% of Kodiak Sciences' outstanding common stock.
View full filing details →Kodiak Sciences announced that its Phase 3 DAYBREAK study for Zenkuda and tabirafusp-ted met primary endpoints in wet age-related macular degeneration.
View full filing details →Has KOD ever done a stock split?
No stock splits are recorded for KOD.
What is KOD's share float?
Get Real-Time KOD Intelligence
SEPT X-Ray combines SEC filings with price targets, support/resistance levels, and smart money tracking — updated every 30 minutes.
Try SEPT X-Ray Free